IRA matches BIOSECURE in driving CDMO sector in India - BioProcess International

Summary

The article discusses the impact of the BIOSECURE Act on the biopharma industry, emphasizing national security concerns with Chinese companies like WuXi AppTec. It explores how Indian CMOs, like Biocon, are poised to fill the resulting supply chain gap, navigating challenges presented by both the BIOSECURE Act and inflation measures such as the IRA.